Evidence map›Paper›PMID 36769697›Full record

ArticleJournal of clinical medicine2023

Pleural Effusion in COVID-19 Pneumonia: Clinical and Prognostic Implications-An Observational, Retrospective Study.

Sara Cappelli, Elisabetta Casto, Marta Lomi, Alessandra Pagano, Luciano Gabbrielli, Roberta Pancani, Ferruccio Aquilini, Giulia Gemignani, Laura Carrozzi, Alessandro Celi

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sara CappelliDepartment of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, 56126 Pisa, Italy.
Elisabetta CastoDepartment of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, 56126 Pisa, Italy.
Marta LomiDepartment of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, 56126 Pisa, Italy.
Alessandra PaganoDepartment of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, 56126 Pisa, Italy.
Luciano GabbrielliPneumology Unit, Pisa University Hospital, 56126 Pisa, Italy.
Roberta PancaniPneumology Unit, Pisa University Hospital, 56126 Pisa, Italy.ORCID 0000-0001-6835-0937
Ferruccio AquiliniOU Organization of Hospital Services, Pisa University Hospital, 56126 Pisa, Italy.
Giulia GemignaniOU Organization of Hospital Services, Pisa University Hospital, 56126 Pisa, Italy.
Laura CarrozziDepartment of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, 56126 Pisa, Italy.
Alessandro CeliDepartment of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-1364-9568

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 presents with a wide spectrum of clinical and radiological manifestations, including pleural effusion. The prevalence and prognostic impact of pleural effusion are still not entirely clear. PATIENTS AND

methodsThis is a retrospective, single-center study including a population of consecutive patients admitted to the University Hospital of Cisanello (Pisa) from March 2020 to January 2021 with a positive SARS-CoV-2 nasopharyngeal swab and SARS-CoV-2-related pneumonia. The patients were divided into two populations based on the presence (

resultsThe prevalence of pleural effusion was 23%. Patients with pleural effusion showed worse gas exchange (

conclusionsPleural effusion associated with SARS-CoV-2 pneumonia is a relatively frequent finding that is confirmed to be a negative prognostic factor. Identifying early prognostic factors in an endemic-prone disease such as COVID-19 is necessary to optimize its clinical management. Further clinical studies aimed at better characterizing pleural effusion in these patients will be appropriate in order to clarify its pathogenetic role.

Indexed as

computer tomographyCOVID-19intensity of carelength of hospitalizationmortalitypleural effusionprognosistotal severity score

Identifiers

PMID36769697
PMCPMC9917650

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.